4.5 Article

Longitudinal assessment of hepatocellular carcinoma response to stereotactic body radiation using gadoxetate-enhanced MRI: A case series

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review

Endrit Shahini et al.

Summary: HCC is the most common primary liver cancer, and its mortality rate is increasing globally. Early diagnosis is critical, and combining novel biomarkers with traditional ones can enhance HCC detection sensitivity. Developing new diagnostic tools and prognostic scores may improve patients' survival.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Response evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: magnetic resonance imaging findings

Zhijun Mai et al.

Summary: This study aimed to summarize the MRI manifestations of hepatocellular carcinoma (HCC) with and without progression after stereotactic body radiation therapy (SBRT) and evaluate the treatment effect using the modified Liver Reporting and Data System (LI-RADS). The results showed that the signal intensity and enhancement patterns of HCCs exhibited a temporal evolution after SBRT. Tumor growth, arterial phase hyperenhancement (APHE) and wash-out, and increased signal intensity on T2WI/DWI indicated tumor progression.

ABDOMINAL RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation

Katerina Mastrocostas et al.

Summary: The study examined the imaging findings of hepatocellular carcinoma (HCC) patients treated with stereotactic body radiation therapy (SBRT) prior to liver transplantation (LT), and found that radiologic assessment may underestimate the degree of tumor necrosis compared to pathology.

ABDOMINAL RADIOLOGY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

SBRT for HCC: Overview of technique and treatment response assessment

Kimberly L. Shampain et al.

Summary: SBRT is an emerging locoregional treatment for HCC, with decision-making and assessment of treatment response requiring a multidisciplinary approach. Continuous imaging evaluation is crucial for guiding patient management and avoiding misinterpretation of post-treatment changes.

ABDOMINAL RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Natural history of hepatocellular carcinoma after stereotactic body radiation therapy

Mishal Mendiratta-Lala et al.

ABDOMINAL RADIOLOGY (2020)

Article Oncology

Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up

Mishal Mendiratta-Lala et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Gastroenterology & Hepatology

Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy

Xiao-Li Sun et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2019)

Article Oncology

Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy

Mishal Mendiratta-Lala et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm

Ania Kielar et al.

ABDOMINAL RADIOLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Article Oncology

RECIST 1.1-Update and clarification: From the RECIST committee

Lawrence H. Schwartz et al.

EUROPEAN JOURNAL OF CANCER (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review

Mustafa M. Haddad et al.

ABDOMINAL RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatic imaging following intra-arterial embolotherapy

Joseph Ralph Kallini et al.

ABDOMINAL RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma

Yuko Nakamura et al.

JAPANESE JOURNAL OF RADIOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma

Yuko Nakamura et al.

JAPANESE JOURNAL OF RADIOLOGY (2015)

Article Gastroenterology & Hepatology

CT Imaging Findings after Stereotactic Radiotherapy for Liver Tumors

Olga R. Brook et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)

Review Oncology

Stereotactic Body Radiotherapy

John P. Kirkpatrick et al.

CANCER (2014)

Review Gastroenterology & Hepatology

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

Riccardo Lencioni et al.

SEMINARS IN LIVER DISEASE (2010)

Article Oncology

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

Kyle E. Rusthoven et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Review Gastroenterology & Hepatology

Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference

J Bruix et al.

JOURNAL OF HEPATOLOGY (2001)